Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41577-021-00522-1

http://scihub22266oqcxt.onion/10.1038/s41577-021-00522-1
suck pdf from google scholar
33723416!7958099!33723416
unlimited free pdf from europmc33723416    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33723416      Nat+Rev+Immunol 2021 ; 21 (4): 245-256
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The first 12 months of COVID-19: a timeline of immunological insights #MMPMID33723416
  • Carvalho T; Krammer F; Iwasaki A
  • Nat Rev Immunol 2021[Apr]; 21 (4): 245-256 PMID33723416show ga
  • Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan, China, in December 2019, the novel coronavirus that causes this disease - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - has spread throughout the world, igniting the twenty-first century's deadliest pandemic. Over the past 12 months, a dizzying array of information has emerged from numerous laboratories, covering everything from the putative origin of SARS-CoV-2 to the development of numerous candidate vaccines. Many immunologists quickly pivoted from their existing research to focus on coronavirus disease 2019 (COVID-19) and, owing to this unprecedented convergence of efforts on one viral infection, a remarkable body of work has been produced and disseminated, through both preprint servers and peer-reviewed journals. Here, we take readers through the timeline of key discoveries during the first year of the pandemic, which showcases the extraordinary leaps in our understanding of the immune response to SARS-CoV-2 and highlights gaps in our knowledge as well as areas for future investigations.
  • |Angiotensin-Converting Enzyme 2/metabolism[MESH]
  • |Antibodies, Viral/immunology[MESH]
  • |Autoantibodies/immunology[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |COVID-19 Serotherapy[MESH]
  • |COVID-19 Vaccines/therapeutic use[MESH]
  • |COVID-19/*immunology/prevention & control/therapy[MESH]
  • |Dexamethasone/therapeutic use[MESH]
  • |Drug Development[MESH]
  • |Glucocorticoids/therapeutic use[MESH]
  • |Humans[MESH]
  • |Immunization, Passive[MESH]
  • |Immunologic Factors/therapeutic use[MESH]
  • |Interferon Type I/immunology[MESH]
  • |Receptors, Coronavirus/metabolism[MESH]
  • |SARS-CoV-2/genetics/*immunology/metabolism/pathogenicity[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box